Compare WGS & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WGS | GBDC |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Finance: Consumer Services |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | N/A | 2010 |
| Metric | WGS | GBDC |
|---|---|---|
| Price | $134.17 | $13.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $138.13 | $14.83 |
| AVG Volume (30 Days) | 380.3K | ★ 1.6M |
| Earning Date | 10-28-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 11.81% |
| EPS Growth | N/A | ★ 4.09 |
| EPS | 0.07 | ★ 1.42 |
| Revenue | $402,190,000.00 | ★ $870,777,000.00 |
| Revenue This Year | $41.17 | N/A |
| Revenue Next Year | $23.53 | N/A |
| P/E Ratio | $1,856.53 | ★ $9.57 |
| Revenue Growth | ★ 50.50 | 20.16 |
| 52 Week Low | $55.17 | $12.68 |
| 52 Week High | $170.87 | $16.01 |
| Indicator | WGS | GBDC |
|---|---|---|
| Relative Strength Index (RSI) | 37.43 | 40.44 |
| Support Level | $133.00 | $13.29 |
| Resistance Level | $143.95 | $13.57 |
| Average True Range (ATR) | 6.96 | 0.20 |
| MACD | -2.89 | -0.05 |
| Stochastic Oscillator | 6.64 | 25.11 |
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.